Phase 2 clinical trial initiated and enrollment progressing across 24 sites
Study to support proof-of-concept mechanism with top line data expected mid-2020
PR Newswire
LEXINGTON, Mass., Sept. 18, 2019
PR Newswire
LEXINGTON, Mass., Sept. 18, 2019
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey